Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats

Medical Science Monitor

Volumn 9, Issue 10, 2003, Pages

  Stover, John F ^a,b   Sakowitz, Oliver W ^a   Schöning, Britta ^a   Rupprecht, Stefan ^a   Kroppenstedt, Stefan N ^a   Thomale, Ulrich W ^a   Woiciechowsky, Christian ^a   Unterberg, Andreas W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Brain edema; Catecholamines; Controlled cortical impact; Cytokines; Secondary damage; Traumatic brain injury

Indexed keywords

CATECHOLAMINE; INTERLEUKIN 6; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN PERFUSION; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE RELEASE; MALE; NONHUMAN; PLASMA; RAT;

ANIMALS; BRAIN INJURIES; EDEMA; INTERLEUKIN-6; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; TIME FACTORS;

EID: 0142184233     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Heinrich PC: Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J, 1999; 265: 621-636
2. Carlson NG, Wieggel WA, Chen J et al: Inflammatory cytokines IL-α, IL-Iβ, II.-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways. J Immunol, 1999; 163: 3963-3968
3. Campbell IL: Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Res Rev, 1998; 26: 327-336
4. Brett FM, Mizisin AP, Powell HC et al: Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol, 1995; 54: 766-775
5. Saija A, Princi P, Lanza M et al: Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci, 1995; 56: 775-784
6. Farkas G, Marton J, Nagy Z et al: Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin-6. Neurosci Lett, 1998; 242: 147-150
7. Gluser MP, Zanetti G, Baumgartner JD et al: Septic shock: pathogenesis. Lancet, 1991; 338: 732-736
8. Benveniste EN: Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol, 1992; 263: C1-G6
9. Le JM, Vilcek J: Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase response. Lab Invest 1989; 61: 588-602
10. Taupin V, Toulmond S, Serrano A et al: Increase in IL-6, IL-1 TNF levels in rat brain following traumatic lesion. J Neuroimmunol, 1993; 42: 177-186
11. Woodroofe MN, Sarna GS, Wadhwa M et al: Detection interleukin-1 and interleukin-6 in adult rat brain following mechanical injury by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol, 1991; 33: 227-236
12. Yan HQ, Banos MA, Hooghe R et al: Expression of interleukin (Il)-Iβ, II.-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol, 1992; 22: 2963-2971
13. Shohami E, Novikov M, Bass R et al: Closed head injury triggers early production of TNF-α and 1L-6 by braiu tissue. J Cereb Blood Flow Metab, 1994; 14: 615-619
14. Shohami F., Gallily R, Mechoulam R et al: Cytokine production in the brain followiug closed head injury: dexanibol (HU-21 I) is a novel TNF-α inhibitor and an effective neuprotectant. J Neuroimmunol, 1997; 72: 169-177
15. Knoblach SM, Fan L, Faden AI: Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment. J Neuroimmunol, 1999; 95: 115-125
16. Hans VM, Kossmann, Lenzlinger PM et al: Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cereblospinal fluid. J Cereb Blood Flow Metab, 1999; 19: 184-194
17. Hans VHJ, Kossmann T, Joller H et al: Interleukin-6 and its soluble receptor in serum aud cerebrospinal flu0id after cerebral trauma. Nueroreport, 1999; 10: 409-412
18. Stover JF, Schöning P, Beyer TF et al: Temporal profile of cerebrospinal fluid glulamate, interleukin-6, and tumor necrosis factor-α in relation to brain edema and contusion following controlled cortical impact injury in rats. Neurosci Lett. 2000; 288: 25-28
19. Kossmann T, Hans VHJ, Imhof H-G et al: Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock, 1995; 4: 311-317
20. Minambres E, Cemborain A, Sanchez-Velasco P et al: Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med, 2003; 31: 933-938
21. Singhal A, Baker AJ, Hare GM et al: Association betwen cerebrospinal fluid interleukin-6 concentrations and outome after severe human traumatic brain injury. J Neurotrauma, 2002; 19: 929-937
22. Woiciechowsky G, Schoning B, Cobanov J et al: Early IL-6 plasma concentrations correlate with severity of brain injury and pneumouia in brain-injured patients. J Trauma, 2002; 52: 339-345
23. Heesen M, Deinsberger W, Dietrich GV et al: Increase of interleukin-6 plasma levels after elective craniotomy: influeuce of interleukin-10 and catecholamines. Acta Neurochir, 1996; 183: 77-80
24. Woiciechowsky C, Asadullah K, Nestler D et al: Different release of cytokines into the cerebrospinal fluid following surgery for intra- and axtra-axial brain tumours. Acta Neurochim, 1997; 139: 619-624
25. Romero LI, Kakucska I, Lechan RM et al: Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-I befa in rats. Am J Physiol, 1996; 270: R518-524
26. Chen G, Castro WL, Chow H H et al: Clearance of 1251-labeled interleukin-6 from brain into blood following intracerebroventricular injection in rats. Eudocrinoloy, 1997; 138: 4830-4836
27. Xiao E, Xia L, Ferin M et al: Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate. J Neuroimmunol, 1999; 97: 70-76
28. Ferrarese C, Mascarucci P, Zoia C et al: Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab, 1999; 19: 1004-1009
29. Gorniekiewicz A, Sautner T, Bostjan C et al: Catecholamines upregulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J, 2000; 14: 1093-1100
30. Jung BD, Kimura K, Kitamura H et al: Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepalocytes. J Biochim, 2000; 127: 205-209
31. Maimone D, Cioni C, Rosa S et al: Norepinephrine and vasoactive intestinal peptide induce 1L-6 secretion by astrocytes: synergism with IL-lα and TNFα. J Neuroimmunol, 1993; 47: 73-82
32. Norris JG, Benveniste EN: Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol, 1993; 45: 137-146
33. DeRijk RH, Boelen A, Tilders FJ et al: Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology, 1994; 19: 155-163
34. Brain Trauma Foundation, American Association of Neurological Surgeons & Joint Section on Neurotrauma and Critical Care: Guidelines for the management of severe traumatic brain injury. J Neurotrauma, 2000; 17: 597-1127
35. Baskaya MK, Rao AM, Dogan A et al: The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci Lett, 1997; 226: 33-36
36. Kochanek PM, Marion DW, Zhang W et al: Severe controlled cortical impact in rats: assessment of cerebral edema, blood flow, and contusion volume. J Neurotrauma, 1995; 12: 1015-1025
37. Kroppenstedt S, Sakowitz O, Thomale U et al: Influence of norepinephrine and dopamine on cortical perfusion, EEG activity, extracellular glutamate and brain edema in rats following controlled cortical impact injury. J Neurotrauma, 2002; 19: 1421-1432
38. Schöning B, Elepfandt P, Lanksch WR et al: Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects. Brain Res Protoc, 1999; 4:217-222
39. Stover JF, Sakowitz OW, Thomale UW et al: Norepinephrine-induced hyperglycemia does not increase cortical lactate in brain-injured rats. Intensive Care Medicine, 2002; 28: 1491-1497
40. van Wagoner NJ, Benveniste EN: Interleukin-6 expression and regulation in astrocytes. J Neuruimmunol, 1999; 100: 124-130
41. Penkowa M, Giralt M, Lago N et al: Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol, 2003; 181: 130-148
42. , Swartz KR, Liu F, Sewell D et al: Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res, 2001; 30: 86-95
43. D'Arcangelo G, Tancredi V, Onofri F et al: Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci, 2000; 12: 1241-52
44. Banks WA, Kastin AJ, Gutierrez EG: Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett, 1994; 179: 53-56
45. Mautes et al: Alterations of norepinephrine levels in plasma and CSF of patients after traumatic brain injury in relation to disruption of the blood-brain barrier. Acta Neurochir, 2001; 143: 51-7
46. Maruo U, Morita I, Shirao M et al: IL-6 increases endothelial permeability in vitro, Endocrinology, 1992; 131: 710-714
47. Cohen T, Nahari D, Weiss Cerem I. et al: Interleukin-6 induces the expression of vascular endothelial growth factor. J Biol Chem, 1996; 271: 736-741